EXPRESS SCRIPTS EXEC SEES RELIEF AHEAD ON DRUG COSTS; QA DR. STEVE MILLER

The rising cost of prescription drugs has come under the spotlight in recent months, with drug price sticker shock and pharmaceutical companies' pricing practices the subject of numerous congressional panels, a presidential campaign talking point and a thorn in the side of employers working to...

Full description

Saved in:
Bibliographic Details
Published inBusiness Insurance Vol. 50; no. 11; p. 12
Main Author Livingston, Shelby
Format Journal Article Trade Publication Article
LanguageEnglish
Published Chicago Crain Communications, Inc 23.05.2016
Crain Communications, Incorporated
Subjects
Anti-inflammatory agents
Biological products
Business insurance
Corporate officers
Corporate planning
Cost control
Costs
Diabetes
Drug formularies
Forecasts and trends
Health maintenance organizations
Hepatitis C
Industrywide conditions
Insulin
Insurance
Interviews
Miller, Steve
Officials and employees
Pharmaceutical industry
Pharmacists
Pharmacy
Pharmacy benefit management
Prescription drugs
Prescription pricing
United States
United States > US
Online AccessGet full text

Cover

More Information
Summary:The rising cost of prescription drugs has come under the spotlight in recent months, with drug price sticker shock and pharmaceutical companies' pricing practices the subject of numerous congressional panels, a presidential campaign talking point and a thorn in the side of employers working to rein in benefit costs. Dr. Steve Miller, chief medical officer for the nation's largest pharmacy benefit manager (PBM), Express Scripts Holding Co., is at the forefront of the conversation. In an interview, Dr. Miller about the the PBM's focus for 2016 and beyond.
ISSN:0007-6864
1557-7791